Aqr Capital Management LLC X Biotech Inc. Transaction History

Aqr Capital Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.13 - $9.2 $150,642 - $270,158	-29,365 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.64 - $11.71 $339,396 - $459,992	-39,282 Reduced 57.22%	29,365 $254,000
Q4 2021 Feb 14, 2022	BUY	$10.95 - $16.07 $122,661 - $180,016	11,202 Added 19.5%	68,647 $764,000
Q3 2021 Nov 15, 2021	BUY	$12.95 - $18.24 $346,295 - $487,755	26,741 Added 87.09%	57,445 $744,000
Q2 2021 Aug 16, 2021	SELL	$15.83 - $17.84 $429,040 - $483,517	-27,103 Reduced 46.89%	30,704 $508,000
Q1 2021 May 17, 2021	SELL	$15.92 - $20.3 $52,201 - $66,563	-3,279 Reduced 5.37%	57,807 $993,000
Q4 2020 Feb 16, 2021	SELL	$15.65 - $19.92 $40,830 - $51,971	-2,609 Reduced 4.1%	61,086 $956,000
Q3 2020 Nov 16, 2020	SELL	$13.97 - $21.16 $206,853 - $313,316	-14,807 Reduced 18.86%	63,695 $1.22 Million
Q2 2020 Aug 17, 2020	BUY	$10.39 - $16.07 $353,176 - $546,251	33,992 Added 76.37%	78,502 $1.08 Million
Q1 2020 May 15, 2020	BUY	$8.89 - $24.94 $148,062 - $415,375	16,655 Added 59.79%	44,510 $473,000
Q4 2019 Feb 14, 2020	BUY	$8.33 - $19.95 $44,248 - $105,974	5,312 Added 23.56%	27,855 $520,000
Q3 2019 Nov 14, 2019	BUY	$6.86 - $10.46 $154,644 - $235,799	22,543 New	22,543 $236,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $203M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.